Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2019 Feb 20;15(4):786–799. doi: 10.1080/21645515.2018.1554971

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2019 GlaxoSmithKline Biologicals SA. Published with license by Taylor & Francis Group, LLC.

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PMC Copyright notice

Figure 4. — Study design.

Footnote: , blood sampling; , vaccine administration (includes administration of DTaP-IPV and VV in sub-cohort 1); AEs, adverse events; DTaP-IPV, diphtheria, tetanus, acellular pertussis, and inactivated polio vaccine; NOCDs, new onset chronic diseases; SAEs, serious adverse events; VV, varicella vaccine.*Drowsiness and loss of appetite were recorded as solicited general AE from Day 0 to Day 3 in sub-cohort 1 only.

Inline graphic — Study design.

Footnote: , blood sampling; , vaccine administration (includes administration of DTaP-IPV and VV in sub-cohort 1); AEs, adverse events; DTaP-IPV, diphtheria, tetanus, acellular pertussis, and inactivated polio vaccine; NOCDs, new onset chronic diseases; SAEs, serious adverse events; VV, varicella vaccine.*Drowsiness and loss of appetite were recorded as solicited general AE from Day 0 to Day 3 in sub-cohort 1 only.